Recherche avancée
Affichage des résultats 7061 à 7080 sur 8263 au total
-
Insects and incest: Sib‐mating tolerance in natural populations of a parasitoid wasp
Marie Collet, Isabelle Amat, Sandrine Sauzet, Alexandra Auguste, Xavier Fauvergue, Laurence Mouton, Emmanuel Desouhant
-
Inferring insect feeding patterns from sugar profiles: a comparison of statistical methods
Martin Luquet, Nicolas Parisey, Maxime Hervé, Emmanuel Desouhant, Anne‐marie Cortesero, Ainara Peñalver‐cruz, Blas Lavandero, Sylvia Anton, Bruno Jaloux
-
Microorganisms Associated with Mosquito Oviposition Sites: Implications for Habitat Selection and Insect Life Histories
Maxime Girard, Edwige Martin, Laurent Vallon, Vincent Raquin, Christophe Bellet, Yves Rozier, Emmanuel Desouhant, Anne-Emmanuelle Hay, Patricia Luis, Claire Valiente Moro, Guillaume Minard
-
Le Projet INDANA : Méta-analyse sur données individuelles des essais cliniques du traitement médicamenteux de l'hypertension artérielle
François Gueyffier
-
Pharmacogenetics and responders to a therapy: Theoretical background and practical problems
J.-P. Boissel, François Gueyffier, Michel Cucherat, G. Bricca
-
Absolute benefit number needed to treat and gain in life expectancy: which efficacy indices for measuring the treatment benefit?
Behrouz Kassai, François Gueyffier, J.-P. Boissel, F. Boutitie, Michel Cucherat
-
How should therapeutic information be transferred to users?
J.-P. Boissel, M. Haugh, M. Fardeheb, Patrice Nony, François Gueyffier, N. Strang
-
Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments
J.-P. Boissel, François Gueyffier, F. Boutitie, S. Pocock, R. Fagard
-
Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome
J.-G. Wang, J.A. Staessen, S. Franklin, R. Fagard, François Gueyffier
-
The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests
Behrouz Kassai, N.R. Shah, A. Leizorovicz, Michel Cucherat, François Gueyffier, J.-P. Boissel
-
Estimation of attributable burden of disease: authors' reply
François Gueyffier, Jm. Wright
-
Safety of computerized drug management: a case report
K.-A. Nguyen, T. Vial, François Gueyffier, S. Marignier, P. Cochat, Behrouz Kassai
-
The lower the better: Does simplicity lead to absurdity?
François Gueyffier, Jm. Wright
-
Cardiovascular Risk Stratification in Decision Support Systems: A Probabilistic Approach. Application to pHealth
H. Atoui, J. Fayn, François Gueyffier, P. Rubel
-
The JIKEI trial
F. Boutitie, François Gueyffier, Jm. Achard
-
Does a change in angiotensin-II-formation caused by antihypertensive drugs affect the risk of stroke ? A meta-analysis of trials according to treatment with potentially different effects on angiotensin-II
F. Boutitie, R. Oprisiu, J.M. Achard, H. Mazouz, J. Wang, F.H. Messerli, François Gueyffier, A. Fournier
-
Severe myoclonic epilepsy in infancy: A systematic review and a meta-analysis of individual patient data
Behrouz Kassai, C. Chiron, S. Augier, Michel Cucherat, E. Rey, François Gueyffier, R. Guerrini, J. Vincent, O. Dulac, Gérard Pons
-
Meta-analysis of continuous outcomes combining individual patient data and aggregate data
Rd. Riley, Pc. Lambert, Ja. Staessen, J. Wang, François Gueyffier, L. Thijs, F. Boutitie
-
New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear
J.-P. Boissel, Michel Cucherat, P. Nonyc, Sylvie Chabaud, François Gueyffier, Jm. Wright, M. Lièvre, A. Leizorovicz
-
SCORE should be preferred to Framingham to predict cardiovascular death in French population
I. Marchant, J-P. Boissel, Behrouz Kassai, T. Bejan-Angoulvant, J. Massol, C. Vidal, E. Amsallem, F. Naudin, P. Galan, S. Czernichow, Patrice Nony, François Gueyffier